US pulls GSK's COVID drug as omicron sibling dominates cases - The Associated Press - en Español
4/5/2022 12:00:00 AM3 yearsago
by Matthew Perrone
by Matthew Perrone
WASHINGTON (AP) — GlaxoSmithKline’s IV drug for COVID-19 should no longer be used because it is likely ineffective against the omicron subvariant that now accounts for most U.S. cases, federal health regulators said Tuesday.
WASHINGTON (AP) GlaxoSmithKlines IV drug for COVID-19 should no longer be used because it is likely ineffective against the omicron subvariant that now accounts for most U.S. cases, federal health re… [+2509 chars]
full article...